Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E MacDougall

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|September 15, 2005
A method for fitting regression splines with varying polynomial order in the linear mixed modelLloyd J Edwards, Paul W Stewart, James E MacDougall, et al.
The American Journal of Gastroenterology|December 23, 2008
Pilot study on the effect of linaclotide in patients with chronic constipationJeffrey M Johnston, Caroline B Kurtz, Douglas A Drossman, et al.
Gastroenterology|January 5, 2010
Efficacy of linaclotide for patients with chronic constipationAnthony J Lembo, Caroline B Kurtz, James E Macdougall, et al.
Gastroenterology|August 31, 2010
Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipationJeffrey M Johnston, Caroline B Kurtz, James E Macdougall, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 1, 2013
Effect of linaclotide on severe abdominal symptoms in patients with irritable bowel syndrome with constipationSatish S C Rao, Eamonn M M Quigley, Steven J Shiff, et al.
United European Gastroenterology Journal|February 6, 2015
Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-CMichael Camilleri, Anthony J Lembo, Bernard J Lavins, et al.
The American Journal of Gastroenterology|September 19, 2012
Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safetyWilliam D Chey, Anthony J Lembo, Bernard J Lavins, et al.
The American Journal of Gastroenterology|September 19, 2012
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipationSatish Rao, Anthony J Lembo, Steven J Shiff, et al.
The New England Journal of Medicine|August 12, 2011
Two randomized trials of linaclotide for chronic constipationAnthony J Lembo, Harvey A Schneier, Steven J Shiff, et al.
Gastroenterology|August 21, 2013
Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphateJoel Castro, Andrea M Harrington, Patrick A Hughes, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|September 15, 2005
A method for fitting regression splines with varying polynomial order in the linear mixed modelLloyd J Edwards, Paul W Stewart, James E MacDougall, et al.
The American Journal of Gastroenterology|December 23, 2008
Pilot study on the effect of linaclotide in patients with chronic constipationJeffrey M Johnston, Caroline B Kurtz, Douglas A Drossman, et al.
Gastroenterology|January 5, 2010
Efficacy of linaclotide for patients with chronic constipationAnthony J Lembo, Caroline B Kurtz, James E Macdougall, et al.
Gastroenterology|August 31, 2010
Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipationJeffrey M Johnston, Caroline B Kurtz, James E Macdougall, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 1, 2013
Effect of linaclotide on severe abdominal symptoms in patients with irritable bowel syndrome with constipationSatish S C Rao, Eamonn M M Quigley, Steven J Shiff, et al.
United European Gastroenterology Journal|February 6, 2015
Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-CMichael Camilleri, Anthony J Lembo, Bernard J Lavins, et al.
The American Journal of Gastroenterology|September 19, 2012
Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safetyWilliam D Chey, Anthony J Lembo, Bernard J Lavins, et al.
The American Journal of Gastroenterology|September 19, 2012
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipationSatish Rao, Anthony J Lembo, Steven J Shiff, et al.
The New England Journal of Medicine|August 12, 2011
Two randomized trials of linaclotide for chronic constipationAnthony J Lembo, Harvey A Schneier, Steven J Shiff, et al.
Gastroenterology|August 21, 2013
Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphateJoel Castro, Andrea M Harrington, Patrick A Hughes, et al.
Pageof 2